Marcos Eduardo Passos da Silva

Marcos Eduardo Passos da Silva

Auto-generated profile, based on publicly available information

Marcos Eduardo Passos da Silva

Postgraduate Program in Experimental Biology, Federal University of Rondônia, Porto Velho, Rondônia, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2023 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
MGMaicon Aleandro da Silva Gomes
Maicon Aleandro da Silva Gomes
RRRenata Santos Rodrigues
Renata Santos Rodrigues
NLNucia Cristiane da Silva Lima
Nucia Cristiane da Silva Lima
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
NMNajla Benevides Matos
Najla Benevides Matos
Acinetobacter spp. are one of the main pathogens responsible for healthcare-associated infections and are associated with high rates of morbidity and mortality globally, mainly because of their high capacity to present and develop resistance to antimicrobials. To identify species of the Acinetobacter and their resistance profiles from samples collected from hospitalized patients, health professionals and hospital environmental sources in the intensive care units of different public reference hospitals in Porto Velho City, Rondônia, Western Brazilian Amazon. Isolates were identified using microbiological and molecular techniques. The antimicrobial susceptibility profile was determined by disk diffusion. A total of 201 Acinetobacter spp. isolates were identified, of which 47.3% originated from hospital structures, 46.8% from patients and 6% from healthcare professionals. A. baumannii and A. nosocomialis were the most prevalent, with frequency of 58.7% and 31.8%, respectively. Regarding the susceptibility profile, it was observed that 56.3% were classified as multidrug-resistant and 76.2% of the samples belonging to A. baumannii were resistant to carbapenems. In contrast, 96.9% were susceptible to polymyxin B and 91.3% to doxycycline. The data presented here can be used to guide and strengthen the control of multidrug-resistant infections caused by Acinetobacter spp., in addition to improving providing information from a traditionally unassisted region of Brazil.

1 January 2024 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
RRR. S. Rodrigues
R. S. Rodrigues
ACA. G. Carvalho
A. G. Carvalho
MSM. E. P. Silva
M. E. P. Silva
IRI. V. G. Ramos
I. V. G. Ramos
NLN. C. S. Lima
N. C. S. Lima
NMN. B. Matos
N. B. Matos
Klebsiella spp. is an opportunistic pathogen which poses a significant threat to public health, especially due to antimicrobial resistance and biofilm formation. This study aimed to determine the antibiotic resistance profile, biofilm formation and β-lactamases production in Klebsiella spp. strains from clinical samples obtained from hospitalized patients, health professionals and hospital environment of intensive care units (ICUs) in Brazilian Amazon. The strains were obtained from clinical samples in different hospitals and identified using molecular techniques. The antimicrobial susceptibility was investigated via disk diffusion and microdilution. Biofilm formation was evaluated using a microtiter plate assay, while the extended-spectrum β-lactamases (ESBL) and carbapenemases production was assessed via disk approximation tests and combined disk tests, respectively. A total of 226 Klebsiella spp. strains were identified, with 141 coming from patients hospitalized in ICUs, 54 from healthcare workers, and 31 from hospital structures. Collection sites that showed the highest frequencies of isolated bacteria were the armpit (43,3%), oral cavity (42.6%), nasal cavity (70.4%), beds (54.8%) and mechanical ventilation (19.4%). Klebsiella spp. isolates from hospitalized patients and hospital ICU environments showed a high frequency of resistance (>50%) to the antibiotics, cefuroxime, cefotaxime, ceftriaxone, ciprofloxacin and aztreonam, and greater sensitivity (>70%) to carbapenems, amikacin and polymyxin B. Samples obtained from hospital structures (74.2%) and patients (51.8%) exhibited a high rate of multidrug resistant (MDR) isolates. In addition, 29% of Klebsiella isolates were found to produce ESBL and 15.5% carbapenemases. Biofilm formation was observed in 58.4% (132/226) of the isolates, with percentages of 64.5% (91/141) in hospitalized patients, 51.6% (16/31) on hospital structures, and 46.3% (25/54) among healthcare professionals. These results indicated a high percentage of antibiotics resistance and MDR in isolates from hospital structures and patients, which also showed ability to produce biofilms, ESBL and carbapenemases. Our findings reinforce the need to monitor resistance and adopt measures aimed at preventing the spread of MDR bacteria in ICUs.

1 January 2022 in Brazilian Journal of Biology
Verified
Journal Article
Open access
MSM. E. P. Silva
M. E. P. Silva
JOJ. R. Oliveira
J. R. Oliveira
ACA. G. Carvalho
A. G. Carvalho
DSD. G. Santos
D. G. Santos
NLN. C. S. Lima
N. C. S. Lima
NMN. B. Matos
N. B. Matos
Streptococcus pneumoniae is one of the primary pathogens that are associated with acute respiratory infections (ARI) that cause high rates of morbidity and mortality among children under five years of age in developed and developing countries. This study aimed to determine the prevalence of nasopharyngeal colonization, the antimicrobial resistance profile, and the capacity for biofilm formation by S. pneumoniae isolated from children aged 0-6 years with ARI throughout the Porto Velho-RO. A total of 660 swabs were collected from children with ARI. Molecular and biochemical tests were performed to characterize the isolates. The disk-difusion method and the E-test were used for antimicrobial sensitivity testing (TSA). Biofilm formation capacity was assessed using microtiter plate assays, and serotype detection was acheived using polymerase chain reaction (PCR) analyses. The colonization rate for S. pneumoniae was 8.9% (59/660) and exhibited a high prevalence in children under 23 months of age 64.4% (38/59). The observed serotypes were 9V and 19F with frequencies of 1.7% (1/59) and 13.6% (8/59), respectively. The antimicrobial susceptibility test revealed 100% (59/59) sensitivity to vancomycin. In contrast, trimethoprim and oxacillin exhibited high resistance rates of 76.3% (45/59) and 52.5% (31/59), respectively. Of the biofilm-forming isolates, 54.8% (23/42) possessed resistance to some antimicrobials. In this study, S. pneumoniae showed high rates of antimicrobial resistance and the ability to form biofilms, as these are factors that favor bacterial persistence and can cause serious damage to the host.

11 April 2025 in Brazilian Journal of Oral Sciences
Verified
Journal Article
Open access
PDF file
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
LSLuccas Manoel de Melo Suica
Luccas Manoel de Melo Suica
RRRenata Santos Rodrigues
Renata Santos Rodrigues
IRIzabelly Vitória Gotara Ramos
Izabelly Vitória Gotara Ramos
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
NMNajla Benevides Matos
Najla Benevides Matos
Patients admitted in the Intensive Care Units (ICUs) often experience various oral health issues during their hospitalization, which can lead to a shift in their oral flora from Gram-positive to pathogenic Gram-negative bacteria, including Pseudomonas aeruginosa. Aim: This study aimed to identify the colonization of P. aeruginosa in the oral cavity of ICU patients, as well as to assess its antimicrobial susceptibility profile, phenotypic resistance mechanisms, and biofilm-forming capacity. Methods: Oral cavity samples were collected from patients in ICUs across three public hospitals in Porto Velho, Rondônia, Brazil. Antimicrobial susceptibility testing was performed using the disk diffusion method, phenotypic research on resistance determinants was conducted using a disk method with and without the addition of enzymatic inhibitors, and biofilm formation was assessed by measuring absorbance in microplates. Results: A total of 114 oral cavity samples were obtained, with 28% showing colonization by P. aeruginosa. The antimicrobial susceptibility profile revealed that 93.7% of the isolates were susceptible to Polymyxin B. The highest rate of non-susceptibility was observed with levofloxacin (46.8%), followed by carbapenems: imipenem (43.7%) and meropenem (40.6%). Additionally, 37.5% of the isolates were classified as multidrug-resistant (MDR). In phenotypic research for carbapenemases, 35.7% of the isolates were positive for plasmid-mediated AmpC, and 14.3% were positive for Metallo-β-lactamases. Regarding biofilm production, 75% of the isolates were classified as moderate/strong biofilm producers. Conclusion: Therefore, oral cavity colonization by P. aeruginosa in ICU patients is evident, with notable multidrug resistance to antibiotics, highlighting the need for vigilant monitoring and effective oral hygiene practices for these patients.

25 April 2026 in International Microbiology
Verified
Journal Article
Open access
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
MBMayra Gyovana Leite Belém
Mayra Gyovana Leite Belém
ESErilene de Lima Sinos
Erilene de Lima Sinos
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
RRRenata Santos Rodrigues
Renata Santos Rodrigues
NMNajla Benevides Matos
Najla Benevides Matos
Group B Streptococcus (GBS) is a leading cause of preterm birth and neonatal infection. The COVID-19 pandemic substantially altered healthcare access, antibiotic use, and pathogen circulation. However, its influence on GBS remains poorly understood. This study evaluated temporal changes in GBS colonization, serotypes, and antimicrobial susceptibility among pregnant women in the Brazilian Amazon before, during, and after the COVID-19 pandemic. A total of 1,449 pregnant women at 35–37 weeks of gestation attending public health units in Porto Velho, Brazil, between February 2018 and November 2023 were included. Rectovaginal samples were cultured for GBS detection. Capsular serotyping and antimicrobial susceptibility testing were performed using standardized methods. Colonization prevalence, serotype distribution, and resistance profiles were compared across pre-pandemic, pandemic, and post-pandemic periods. Overall GBS colonization was detected in 20.7% (300/1,449) of participants, with variation across periods (22.6% before the pandemic, 21% during, and 19% after). Serotype Ia predominated (39%), followed by serotypes V (15.8%), II (14.1%), Ib (11.9%), III (10.2%), IV (5.1%), and VI (4%). Serotype distribution varied across periods without statistically significant differences. Non-susceptibility profiles differed significantly among serotypes. All isolates were susceptible to penicillin, ampicillin, cefazolin, and vancomycin. Increased non-susceptibility was observed for macrolides and levofloxacin, with multidrug-resistant (MDR) isolates rising from 5.7% to 15.9% post-pandemic. Together, these findings demonstrate temporal variation in GBS colonization, serotype distribution, and antimicrobial resistance across pre-, during-, and post-pandemic periods. While colonization, serotype distribution, and β-lactam susceptibility remained stable, significant increases in non-susceptibility to macrolides and levofloxacin, along with higher proportions of MDR profiles, were observed in later periods. These results highlight the importance of continued surveillance and provide relevant epidemiological insights to inform vaccine implementation and public health strategies in the post-pandemic era. The online version contains supplementary material available at 10.1007/s10123-026-00832-1.

21 March 2026 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
LSLuccas Manoel de Melo Suica
Luccas Manoel de Melo Suica
RRRenata Santos Rodrigues
Renata Santos Rodrigues
MCMárlon Grégori Flôres Custódio
Márlon Grégori Flôres Custódio
VFValcimar Batista Ferreira
Valcimar Batista Ferreira
NMNajla Benevides Matos
Najla Benevides Matos
Introduction: Pseudomonas aeruginosa is one of the leading agents of Healthcare-Associated Infections (HAIs), especially in Intensive Care Units (ICUs), where its intrinsic resistance, biofilm-forming ability, and acquisition of β-lactamase genes contribute to therapeutic failure and increased morbidity. Understanding the resistance mechanisms and clonal dynamics of this pathogen in clinical and hospital environments is essential for effective infection control. Results: Overall, 30.5% of the isolates were classified as MDR, with higher non-susceptibility rates to imipenem (41.2%) and meropenem (35.6%). Moderate/strong biofilm formation was observed in 77.3% of the isolates. A high prevalence of β-lactamase genes was detected, particularly blaCTX-M (38.8%), blaTEM (29.1%), blaGES (13.9%), and blaSHV (4.1%), whereas carbapenemase genes were infrequent ( blaVIM , blaKPC , blaIMP ; 1.8%). The blaCTX-M gene was significantly associated with MDR profiles and resistance to cefepime and ceftazidime. PFGE identified 16 clonal groups among 28 isolates, indicating transmission among patients, hospital surfaces, and different hospitals. MLST revealed 16 sequence types, including four novel STs, with predominance of ST3079. Methods: A total of 216 P. aeruginosa isolates obtained from hospitalized patients and hospital surfaces in three public hospitals in Porto Velho, Western Amazon, Brazil, were analyzed. Antimicrobial susceptibility was determined according to CLSI guidelines. Biofilm formation was evaluated in 96-well microplates. β-lactamase and carbapenemase genes were detected by PCR. Genetic relatedness was investigated by PFGE and MLST in multidrug-resistant (MDR) or carbapenem-resistant isolates. Conclusion: P. aeruginosa from ICU patients and hospital surfaces showed high multidrug resistance, strong biofilm production, and widespread β-lactamase genes, particularly blaCTX-M , a key determinant of the MDR phenotype. Clonal dissemination across hospitals and sources highlights the need for strengthened infection control, continuous molecular surveillance, and antimicrobial stewardship.